| 2025 | Unveiling the Multifaceted Pharmacological Actions of Indole-3-Carbinol and Diindolylmethane: A Comprehensive Review | Yadava Srikanth | PMC11902694 | https://pmc.ncbi.nlm.nih.gov/articles/PMC11902694/ | 0 |
| 2025 | 3,3′-diindolylmethane induces ferroptosis and inhibits proliferation in non-small-cell lung cancer through the AHR/NRF2/GPX4 axis | Lin Guo | PMC11920504 | https://pmc.ncbi.nlm.nih.gov/articles/PMC11920504/ | 0 |
| 2023 | 3,3′-Diindolylmethane and indole-3-carbinol: potential therapeutic molecules for cancer chemoprevention and treatment via regulating cellular signaling pathways | Octavio Daniel Reyes-Hernández | PMC10464192 | https://pmc.ncbi.nlm.nih.gov/articles/PMC10464192/ | 0 |
| 2022 | 3,3′-Diindolylmethane Enhances Fluorouracil Sensitivity via Inhibition of Pyrimidine Metabolism in Colorectal Cancer | Jieping Zhang | PMC9144298 | https://pmc.ncbi.nlm.nih.gov/articles/PMC9144298/ | 0 |
| 2022 | Studies on the mode of action of synthetic diindolylmethane derivatives against triple negative breast cancer cells | Ganesan Shilpa | 35750657 | https://pubmed.ncbi.nlm.nih.gov/35750657/ | 0 |
| 2022 | Diindolylmethane Promotes Metabolic Crisis and Enhances the Efficacy of Centchroman in Breast Cancer: A 1H NMR-Based Approach | Dhanamjai Penta | PMC9713897 | https://pmc.ncbi.nlm.nih.gov/articles/PMC9713897/ | 0 |
| 2021 | Indoles Derived From Glucobrassicin: Cancer Chemoprevention by Indole-3-Carbinol and 3,3'-Diindolylmethane | David E Williams | PMC8517077 | https://pmc.ncbi.nlm.nih.gov/articles/PMC8517077/ | 0 |
| 2021 | 3,3′-Diindolylmethane Exhibits Significant Metabolism after Oral Dosing in Humans | Monica L Vermillion Maier | PMC8407664 | https://pmc.ncbi.nlm.nih.gov/articles/PMC8407664/ | 0 |
| 2021 | 3,3'-Diindolylmethane Suppresses the Growth of Hepatocellular Carcinoma by Regulating Its Invasion, Migration, and ER Stress-Mediated Mitochondrial Apoptosis | Suvesh Munakarmi | PMC8151225 | https://pmc.ncbi.nlm.nih.gov/articles/PMC8151225/ | 0 |
| 2020 | 3,3'-Diindolylmethane modulates aryl hydrocarbon receptor of esophageal squamous cell carcinoma to reverse epithelial-mesenchymal transition through repressing RhoA/ROCK1-mediated COX2/PGE2 pathway | Peiyao Zhu | PMC7298755 | https://pmc.ncbi.nlm.nih.gov/articles/PMC7298755/ | 0 |
| 2020 | 3,3’-Diindolylmethane and its derivatives: nature-inspired strategies tackling drug resistant tumors by regulation of signal transduction, transcription factors and microRNAs | Bernhard Biersack | PMC8992569 | https://pmc.ncbi.nlm.nih.gov/articles/PMC8992569/ | 0 |
| 2020 | 3,3'-Diindolylmethane Enhances Tumor Regression After Radiation Through Protecting Normal Cells to Modulate Antitumor Immunity | Lijun Li | PMC7811120 | https://pmc.ncbi.nlm.nih.gov/articles/PMC7811120/ | 0 |
| 2017 | A randomized, placebo-controlled trial of diindolylmethane for breast cancer biomarker modulation in patients taking tamoxifen | Cynthia A Thomson | PMC5571834 | https://pmc.ncbi.nlm.nih.gov/articles/PMC5571834/ | 0 |
| 2016 | Chemopreventive properties of 3,3′-diindolylmethane in breast cancer: evidence from experimental and human studies | Cynthia A Thomson | PMC5059820 | https://pmc.ncbi.nlm.nih.gov/articles/PMC5059820/ | 0 |
| 2016 | Phase Ib placebo-controlled, tissue biomarker trial of diindolylmethane (BR-DIMNG) in patients with prostate cancer who are undergoing prostatectomy | Jason R Gee | 26313229 | https://pubmed.ncbi.nlm.nih.gov/26313229/ | 0 |
| 2016 | Anti-androgenic activity of absorption-enhanced 3, 3’-diindolylmethane in prostatectomy patients | Clara Hwang | PMC4759426 | https://pmc.ncbi.nlm.nih.gov/articles/PMC4759426/ | 0 |
| 2015 | A therapeutically relevant, 3,3'-diindolylmethane derivative NGD16 attenuates angiogenesis by targeting glucose regulated protein, 78kDa (GRP78) | Debasis Nayak | 25794856 | https://pubmed.ncbi.nlm.nih.gov/25794856/ | 0 |
| 2015 | 3,3′-Diindolylmethane: A Promising Sensitizer of γ-Irradiation | Wenjing Wang | PMC4633530 | https://pmc.ncbi.nlm.nih.gov/articles/PMC4633530/ | 0 |
| 2015 | Double-blind randomized placebo-controlled multicenter clinical trial (phase IIa) on diindolylmethane's efficacy and safety in the treatment of CIN: implications for cervical cancer prevention | Levon Ashrafian | PMC4685602 | https://pmc.ncbi.nlm.nih.gov/articles/PMC4685602/ | 0 |
| 2013 | DIM (3,3′-diindolylmethane) confers protection against ionizing radiation by a unique mechanism | Saijun Fan | PMC3831962 | https://pmc.ncbi.nlm.nih.gov/articles/PMC3831962/ | 0 |
| 2011 | Effect of diindolylmethane supplementation on low-grade cervical cytological abnormalities: double-blind, randomised, controlled trial | A Castañon | PMC3251847 | https://pmc.ncbi.nlm.nih.gov/articles/PMC3251847/ | 0 |
| 2010 | 3,3'-Diindolylmethane induces a G(1) arrest in human prostate cancer cells irrespective of androgen receptor and p53 status | Omar I Vivar | PMC2706920 | https://pmc.ncbi.nlm.nih.gov/articles/PMC2706920/ | 0 |
| 2010 | A phase I dose-escalation study of oral BR-DIM (BioResponse 3,3'- Diindolylmethane) in castrate-resistant, non-metastatic prostate cancer | Elisabeth I Heath | PMC2923864 | https://pmc.ncbi.nlm.nih.gov/articles/PMC2923864/ | 0 |
| 2009 | Inactivation of uPA and its receptor uPAR by 3, 3'-Diindolylmethane (DIM) leads to the inhibition of Prostate Cancer Cell growth and migration | Aamir Ahmad | PMC2738995 | https://pmc.ncbi.nlm.nih.gov/articles/PMC2738995/ | 0 |
| 2009 | Induction of G1 and G2/M cell cycle arrests by the dietary compound 3,3'-diindolylmethane in HT-29 human colon cancer cells | Hyun Ju Choi | PMC2700124 | https://pmc.ncbi.nlm.nih.gov/articles/PMC2700124/ | 0 |
| 2009 | Single-Dose Pharmacokinetics and Tolerability of Absorption-Enhanced 3, 3′-Diindolylmethane in Healthy Subjects | Gregory A Reed | PMC2602858 | https://pmc.ncbi.nlm.nih.gov/articles/PMC2602858/ | 0 |
| 2008 | Induction of growth arrest and apoptosis in human breast cancer cells by 3,3-diindolylmethane is associated with induction and nuclear localization of p27kip | Zhiwei Wang | 18281517 | https://pubmed.ncbi.nlm.nih.gov/18281517/ | 0 |
| 2006 | Inhibition of breast cancer cell growth and induction of cell death by 1,1-bis(3'-indolyl)methane (DIM) and 5,5'-dibromoDIM | Kathy Vanderlaag | 16051428 | https://pubmed.ncbi.nlm.nih.gov/16051428/ | 0 |
| 2006 | 3,3'-Diindolylmethane is a novel mitochondrial H(+)-ATP synthase inhibitor that can induce p21(Cip1/Waf1) expression by induction of oxidative stress in human breast cancer cells | Yixuan Gong | 16651444 | https://pubmed.ncbi.nlm.nih.gov/16651444/ | 0 |
| 2002 | 3,3'-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression | Chibo Hong | 12151347 | https://pubmed.ncbi.nlm.nih.gov/12151347/ | 0 |
| 1998 | Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane | I Chen | 9771935 | https://pubmed.ncbi.nlm.nih.gov/9771935/ | 0 |
| 2023 | Resveratrol and 3,3'-Diindolylmethane Differentially Regulate Aryl Hydrocarbon Receptor and Estrogen Receptor Alpha Activity through Multiple Transcriptomic Targets in MCF-7 Human Breast Cancer Cells | Siddhartha Das | PMC10572670 | https://pmc.ncbi.nlm.nih.gov/articles/PMC10572670/ | 0 |